Vestmark Advisory Solutions Inc. Boosts Stake in Haleon PLC Sponsored ADR $HLN

Vestmark Advisory Solutions Inc. increased its holdings in shares of Haleon PLC Sponsored ADR (NYSE:HLN) by 48.2% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 148,193 shares of the company’s stock after acquiring an additional 48,196 shares during the period. Vestmark Advisory Solutions Inc.’s holdings in Haleon were worth $1,537,000 as of its most recent SEC filing.

Other large investors have also recently bought and sold shares of the company. Wellington Management Group LLP boosted its position in shares of Haleon by 22.0% during the 1st quarter. Wellington Management Group LLP now owns 18,700,480 shares of the company’s stock worth $192,428,000 after purchasing an additional 3,372,155 shares in the last quarter. Sculptor Capital LP lifted its stake in shares of Haleon by 22.1% in the first quarter. Sculptor Capital LP now owns 10,849,868 shares of the company’s stock valued at $111,645,000 after purchasing an additional 1,962,770 shares during the period. Envestnet Asset Management Inc. lifted its stake in shares of Haleon by 6.5% in the second quarter. Envestnet Asset Management Inc. now owns 7,857,196 shares of the company’s stock valued at $81,479,000 after purchasing an additional 476,823 shares during the period. Nuveen LLC purchased a new stake in Haleon during the first quarter worth about $58,870,000. Finally, Millennium Management LLC grew its position in Haleon by 697.2% during the first quarter. Millennium Management LLC now owns 4,216,504 shares of the company’s stock worth $43,388,000 after buying an additional 3,687,613 shares during the period. Hedge funds and other institutional investors own 6.67% of the company’s stock.

Haleon Price Performance

Shares of NYSE:HLN opened at $9.47 on Monday. The company has a debt-to-equity ratio of 0.48, a quick ratio of 0.63 and a current ratio of 0.87. The business’s fifty day moving average price is $9.28 and its two-hundred day moving average price is $9.92. The stock has a market cap of $42.19 billion, a PE ratio of 24.29, a price-to-earnings-growth ratio of 2.84 and a beta of 0.20. Haleon PLC Sponsored ADR has a one year low of $8.71 and a one year high of $11.42.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on the stock. Barclays cut shares of Haleon from an “overweight” rating to an “equal weight” rating in a report on Tuesday, September 16th. The Goldman Sachs Group raised Haleon from a “neutral” rating to a “buy” rating in a research note on Wednesday, September 10th. Finally, Weiss Ratings reaffirmed a “hold (c)” rating on shares of Haleon in a report on Wednesday, October 8th. One research analyst has rated the stock with a Strong Buy rating, three have issued a Buy rating and six have assigned a Hold rating to the company. According to MarketBeat, Haleon has a consensus rating of “Moderate Buy” and an average target price of $12.33.

Haleon Company Profile

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company provides oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands.